Bingqi Dong

机构：University of Georgia, Peking University, Wenzhou Medical University, Zhengzhou University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Peking University First Hospital · ORCID：0000-0001-8251-1741

发表论文 36 篇 · 总被引 332 次 · h-index 9

代表论文

• The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials (2023 · Pharmacological Research · 被引 79)
• Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis (2023 · Frontiers in Immunology · 被引 33)
• Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis (2023 · Frontiers in Pharmacology · 被引 33)
• Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer (2024 · Advanced Healthcare Materials · 被引 16)
• Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage (2024 · Advanced Science · 被引 13)
• A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer (2023 · Frontiers in Immunology · 被引 9)